Join
Live feed
·
NEWSReleasevia Quantisnow
LianBio logo

LianBio Completes Strategic Review And Determined To Initiate The Wind Down Of Its Operations, Including Sale Of Remaining Pipeline Assets, Delisting Of ADSs And Workforce Reductions; Board Has Declared Special Dividend Of $4.80/Sharea

ByQuantisnow·Wall Street's wire, on your screen.
LIAN· LianBio
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIAN (LianBio) and more on Quantisnow.